Data Generated under Core Studies Sample Clauses

Data Generated under Core Studies. Each Party shall promptly provide the other Party with copies of final reports and of all Information (including preclinical and clinical data) generated in conducting the Core Studies. A Party shall provide such Information to the other as soon as reasonably practical and through information sharing procedures to be established by the JSC. Each Party and its Affiliates, sublicensees and licensees may use any such Information for (i) the performance of the activities under this Agreement, and (ii) the research, Development, manufacture and Commercialization of Product for its Territory (being the Licensed Territory for Norgine and the Retained Territory for Tranzyme); in each case including the regulatory activities relating thereto. Each Party hereby grants to the other Party a fully-paid up right of reference (transferrable by such other Party to its Affiliates, sublicensees and licensees) to all Regulatory Filings made by the first Party (or its Affiliates or (sub)licensees) solely for such other Party to conduct the activities set forth in subsections (i) and (ii) above.
Sample 1
AutoNDA by SimpleDocs

Related to Data Generated under Core Studies

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Originating Switched Access Detail Usage Data A category 1101XX record as defined in the EMI Telcordia Practice BR-010-200- 010.

  • Loop Provisioning Involving Integrated Digital Loop Carriers 2.6.1 Where EveryCall has requested an Unbundled Loop and BellSouth uses Integrated Digital Loop Carrier (IDLC) systems to provide the local service to the end user and BellSouth has a suitable alternate facility available, BellSouth will make such alternative facilities available to EveryCall. If a suitable alternative facility is not available, then to the extent it is technically feasible, BellSouth will implement one of the following alternative arrangements for EveryCall (e.g. hairpinning):

  • Investment Analysis and Implementation In carrying out its obligations under Section 1 hereof, the Advisor shall:

  • SERVICE MONITORING, ANALYSES AND ORACLE SOFTWARE 11.1 We continuously monitor the Services to facilitate Oracle’s operation of the Services; to help resolve Your service requests; to detect and address threats to the functionality, security, integrity, and availability of the Services as well as any content, data, or applications in the Services; and to detect and address illegal acts or violations of the Acceptable Use Policy. Oracle monitoring tools do not collect or store any of Your Content residing in the Services, except as needed for such purposes. Oracle does not monitor, and does not address issues with, non-Oracle software provided by You or any of Your Users that is stored in, or run on or through, the Services. Information collected by Oracle monitoring tools (excluding Your Content) may also be used to assist in managing Oracle’s product and service portfolio, to help Oracle address deficiencies in its product and service offerings, and for license management purposes.

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • STAGE The aggrieved may within twenty-one (21) calendar days after an occurrence, or in the case of disciplinary action within twenty-one (21) calendar days after same has been brought to the attention of the reduce the grievance to writing and accompanied by representatives of the Grievance Committee, take the matter up with the Fire Chief. The Fire Chief shall, within seven (7) calendar days, arrange a meeting place and time to discuss and attempt to settle the grievance. The Corporation will be represented at this stage of the grievance procedure by the Fire Chief and the Director of Human Resources. Grievancesthat are not settled within seven (7)calendar days of the meeting may be referred to Stage provided that not more than seven (7) calendar days have elapsed since the meeting at Stage STAGE2 The aggrieved shall reconsider the grievance and the Fire Chief's response at Stage and decide within five (5) calendar days whether to proceed with the grievance. If the aggrieved wishes to proceed, the Assistant City Manager of Emergency and Corporate Services, the Fire Chief, and the Director of Human Resources will meet with the aggrieved accompanied by representatives of the Grievance Committee within seven (7) calendar days of notification by the aggrieved Failing settlement at this stage, Stage of the grievance procedure may be invoked provided that no more than seven (7) calendar days have elapsed since the hearing at Stage STAGE The aggrieved accompanied by representatives of the Grievance Committee, may then take the written grievance to a committee of Council members. In the case of discharge, the grievance shall be heard by the entire Council. Failing settlement at this stage within fourteen (14) calendar days, then the grievance may be referredto Arbitration, as provided under the "Fire Protectionand Prevention Act Part as amended, provided that not more than thirty

  • Access Toll Connecting Trunk Group Architecture 9.2.1 If CBB chooses to subtend a Verizon access Tandem, CBB’s NPA/NXX must be assigned by CBB to subtend the same Verizon access Tandem that a Verizon NPA/NXX serving the same Rate Center Area subtends as identified in the LERG.

Time is Money Join Law Insider Premium to draft better contracts faster.